Description

Improve your knowledge through this program, where you will find the best didactic material with real clinical cases. Learn here about the latest advances in the specialty to be able to perform a quality medical practice"

##IMAGE## Recent studies have reported a reduction in lung cancer mortality among current and former smokers with a minimum of 30 packs/year following the use of low-dose helical computed tomography, and have provided sufficient evidence to establish strong international recommendations for lung cancer prevention.

Therefore, a more frequent future presentation of lung cancer will be via a solitary pulmonary nodule, a relevant fact given that diagnosis at advanced stages has been the norm in the last 30 years and the reason for the low prevalence of this disease.

Nowadays, talking about oncology means talking about "multidisciplinary teams", about advances in fields of science that are increasingly involved, and this, apart from being interesting, means that we need continuous education that is often difficult to acquire in other courses or congresses since they are oriented to a very specific area and specific to a single specialty.

Not losing this multidisciplinary vision is very important because many advances in one area can have implications in the diagnostic and therapeutic algorithms used in oncology. In fact, one of the skills that we aim for students to achieve with this postgraduate certificate is to have a broad and clear vision of oncology, and to use the comparison of scientific advances in each area as a tool that will allow them to advance their knowledge.

Expand your knowledge through the postgraduate certificate in Treatment of Non-Small Cell Lung Cancer, in a practical way and adapted to your needs”

This ##ESTUDIO## in Treatment of Non-Small Cell Lung Cancer contains the most complete and up-to-date scientific program on the market. The most important features include:

  • Development of clinical cases presented by experts in Thoracic Oncology
  • The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
  • New diagnostic and therapeutic developments on the performance of Thoracic Oncology
  • An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
  • With a special emphasis on evidence-based medicine and research methodologies in Treatment of Non-Small Cell Lung Cancer
  • All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
  • Content that is accessible from any fixed or portable device with an internet connection

This postgraduate certificate is the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge in Treatment of Non-Small Cell Lung Cancer you will obtain a qualification endorsed by TECH Technological University”

Its teaching staff includes health professionals belonging to the field of Thoracic Oncology, who contribute their work experience to this training, in addition to renowned specialists belonging to leading scientific societies.

Thanks to its multimedia content developed with the latest educational technology, it will allow the professional a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to study in real situations.

This program is designed around Problem-Based Learning, whereby the physician must try to solve the different professional practice situations that arise throughout the program. For this reason, they will be assisted by an innovative, interactive video system created by renowned and experienced experts in the field of thoracic oncology who have extensive teaching experience.

The postgraduate certificate includes real clinical cases and exercises to bring the content of the program closer to the clinical practice of a physician"

##IMAGE##

Make the most of this opportunity to update your knowledge in the Treatment of Non-Small Cell Lung Cancer and improve the care of your patients"

Objectives

The main objective of the program is the development of theoretical and practical learning, so that the physician can master in a practical and rigorous way the Treatment of Non-Small Cell Lung Cancer.

##IMAGE##

This program will provide you with the skills to carry out your medical practice with confidence and will help you to grow both personally and professionally”

General Objective

  • Create a global and up-to-date vision of Thoracic Oncology and all its aspects, allowing the student to acquire useful knowledge and at the same time, generate interest in expanding the information and discovering its application in their daily practice

Specific Objectives

  • Describe the therapeutic algorithm for the management of each of the thoracic tumors and in the different stages
  • Interpret the impact of mutations on drug selection
  • Discuss the current landscape of lung cancer immunotherapy, combinations in clinical development, strategies for dose selection and trial design, clinical pharmacology and regulatory considerations
  • Determine the positioning of each agent for the treatment of lung cancer
  • Construct an appropriate treatment plan for a patient with a thoracic tumor at each stage
  • Develop an appropriate treatment plan for patients with non-small cell lung cancer (NSCLC) that has progressed after initial treatment
  • Design a treatment plan for a patient with small cell lung cancer (SCLC)
  • Develop an appropriate treatment plan for a patient with SCLC that has progressed after initial treatment
  • Help improve the diagnosis and management of lower incidence tumors such as neuroendocrine tumors, mesothelioma, thymoma or tumors of the posterior mediastinum and thoracic wall
  • Update of knowledge on disseminated stage non-small cell lung cancer in different topics that, due to their topicality and importance, represent major changes for the clinical practice of any specialist in thoracic tumors
  • Discuss the growing understanding of the molecular biology and immunology of lung tumors and how they are modifying the diagnostic and therapeutic approach

##IMAGE##

Make the most of this opportunity and take the step to get up to date on the latest developments in Treatment of Non-Small Cell Lung Cancer”

Postgraduate Certificate in Treatment of Non-Small Cell Lung Carcinoma of the Lung

According to the American Cancer Society, non-small cell lung cancer (NSCLC) is the most common lung cancer affecting both men and women. Its symptoms are aggressive and existing treatments to date can vary from person to person; these include surgery, radiotherapy, chemotherapy and targeted drug therapy. Given the current panorama of advances in science and technology, it has become meritorious that professionals belonging to the medical sector renew their knowledge in order to remain at the forefront when treating each patient. For this reason, in TECH we have designed a Postgraduate Certificate in Treatment of Non-Small Cell Lung Carcinoma that covers a global and updated vision of thoracic oncology and its aspects. With the syllabus of this program delivered online, students will specialize in creating therapeutic algorithms for NSCLC (non-small cell lung cancer) that contribute to devise appropriate treatments for each individual. Among these algorithms are angiogenic and targeted therapy, stereotactic radiotherapy and concurrent and sequential chemotherapy, among others.

Specialize in the treatment of non-small cell lung cancer.

The School of Medicine of TECH Technological University, with presence in many Spanish-speaking countries, offers you the best didactic material based on real clinical cases; this will contribute to make your learning immersive and totally organic. In the span of the 300 hours of study covered by this program, you will gain a multidisciplinary view of the current landscape of lung cancer immunotherapy. This ranges from combinations in clinical development and trial design; to the use of measured pharmacology to improve the diagnosis of lower incidence conditions such as oligometastatic disease, neuroendocrine, mesothelioma and upper lobe and posterior mediastinal tumors. Therefore, you will be able to manage the diagnostic-therapeutic novelties in thoracic oncology, to treat early stage (I-II) and advanced stage (IIIA-IIIB) thoracic oncology. Due to this, you will be able to apply both surgical and non-surgical techniques, as well as treatments for squamous cell carcinoma and pulmonary adenocarcinoma.